Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Jacobio Pharmaceuticals (1167 HK)
Watchlist
62
Analysis
Health Care
•
China
Jacobio Pharmaceuticals Co. Ltd. operates as a biotech company. The Company develops and sells cancer innovative drugs, autoimmune drugs, infectious diseases drugs, and other products. Jacobio Pharmaceuticals markets its products throughout China.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
10 May 2024 21:49
Voluntary Announcement China Cde Clearance For Phase Iii Clinical Trial Of Kras G12c Inhibitor Glecirasib In Combination With Cetuximab In Patients With Colorectal Cancer
Attachment
Exchange Announcement •
06 May 2024 21:40
Voluntary Announcement Submission Of New Drug Application For Kras G12c Inhibitor Glecirasib
Attachment
Exchange Announcement •
26 Apr 2024 17:08
Form Of Proxy For The 2024 Annual General Meeting
Attachment
Exchange Announcement •
26 Apr 2024 17:06
Notice Of 2024 Annual General Meeting
Attachment
Exchange Announcement •
26 Apr 2024 17:05
Proposed Granting Of General Mandates To Issue Shares And Repurchase Shares, Proposed Re-Election Of Directors, Proposed Change Of Auditor And Notice Of Annual General Meeting
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.2
x